Mechanism and Hold Parameters

Beta blockers block beta-1 receptors in the heart, reducing heart rate, contractility, and myocardial oxygen demand, making them first-line for hypertension, angina, heart failure, and post-MI protection. The universal hold parameter is apical heart rate below 60 bpm or systolic BP below 90-100 mmHg — always check both before administration. Nonselective agents (propranolol) also block beta-2 receptors in the lungs, causing bronchoconstriction, so they're contraindicated in asthma and COPD; cardioselective agents (metoprolol, atenolol) are safer but caution still applies at high doses.

Contraindications and High-Risk Populations

Beta blockers are contraindicated in severe bradycardia, second- or third-degree heart block without a pacemaker, and decompensated heart failure with acute pulmonary edema, though they're a cornerstone of stable chronic heart failure management once titrated slowly. In diabetics, beta blockers mask the tachycardia and tremor of hypoglycemia, leaving diaphoresis as the only reliable warning sign — teach patients to monitor glucose more vigilantly. Use cautiously in peripheral vascular disease since beta blockade can worsen extremity perfusion, causing cold hands and feet.

Patient Teaching and Discontinuation Safety

Never stop a beta blocker abruptly — doing so can cause rebound tachycardia, severe hypertension, and precipitate myocardial infarction or angina due to upregulated beta receptors; doses must be tapered over one to two weeks. Teach patients to rise slowly to prevent orthostatic hypotension and to check pulse before taking their dose, holding and calling the provider if below the prescribed parameter. Patients should avoid abruptly stopping even if they feel fine, and should carry medication information cards for emergency responders given the drug's effect on heart rate response.